Huber elected as PRAC vice-chair
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
The European Medicines Agency’s (EMA’s) Pharmacovigilance Risk Assessment Committee (PRAC) has elected Dr Martin Huber as its new vice-chair. Huber takes over from Dr Álmath Spooner, who served for two three-year mandates as vice-chair, the maximum allowed by the rules of the committee. Dr Sabine Straus now chairs the PRAC.